These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16362392)

  • 21. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
    Dooley MA; Jayne D; Ginzler EM; Isenberg D; Olsen NJ; Wofsy D; Eitner F; Appel GB; Contreras G; Lisk L; Solomons N;
    N Engl J Med; 2011 Nov; 365(20):1886-95. PubMed ID: 22087680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schönlein purpura nephritis.
    Ren P; Han F; Chen L; Xu Y; Wang Y; Chen J
    Am J Nephrol; 2012; 36(3):271-7. PubMed ID: 22965140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study].
    Cailliez M; Bruno D; Daniel L; Afaneti M; Bérard E; Sarles J; Tsimaratos M
    Nephrol Ther; 2008 Feb; 4(1):15-20. PubMed ID: 18096455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.
    Czaja AJ; Carpenter HA
    J Clin Gastroenterol; 2005 Oct; 39(9):819-25. PubMed ID: 16145346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic sarcoidosis after cardiac transplantation in a 9-year-old child.
    Bartram U; Thul J; Bauer J; Wössmann W; Schranz D
    J Heart Lung Transplant; 2006 Oct; 25(10):1263-7. PubMed ID: 17045940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil in pediatric renal transplantation.
    Weber LT; Höcker B; Mehls O; Tönshoff B
    Minerva Urol Nefrol; 2003 Mar; 55(1):91-9. PubMed ID: 12773970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolate mofetil for the treatment of interstitial nephritis.
    Preddie DC; Markowitz GS; Radhakrishnan J; Nickolas TL; D'Agati VD; Schwimmer JA; Gardenswartz M; Rosen R; Appel GB
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):718-22. PubMed ID: 17699278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible renal failure due to isolated renal sarcoidosis.
    Williams PF; Thomson D; Anderton JL
    Nephron; 1984; 37(4):246-9. PubMed ID: 6462314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulomatous nephritis: A rare presentation of juvenile-onset sarcoidosis.
    Chotalia P; Pandya S; Srivastava P
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):111-114. PubMed ID: 34508265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mycophenolate mofetil for the treatment of lupus nephritis. The case of lupus nephritis--class IV according to WHO--treated with mycophenolate mofetil].
    Suszek D; Wielosz E; Majdan M
    Ann Acad Med Stetin; 2010; 56 Suppl 1():91-4. PubMed ID: 21365951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.
    Bitoun S; Bouvry D; Borie R; Mahevas M; Sacre K; Haroche J; Psimaras D; Pottier C; Mathian A; Hie M; Boutin DL; Papo T; Godeau B; Valeyre D; Nunes H; Amoura Z; Cohen Aubart F
    Neurology; 2016 Dec; 87(24):2517-2521. PubMed ID: 27856779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil.
    Höcker B; Weber LT; Feneberg R; Drube J; John U; Fehrenbach H; Pohl M; Zimmering M; Fründ S; Klaus G; Wühl E; Tönshoff B
    Transplantation; 2009 Mar; 87(6):934-41. PubMed ID: 19300199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
    Bhat P; Cervantes-Castañeda RA; Doctor PP; Anzaar F; Foster CS
    Ocul Immunol Inflamm; 2009; 17(3):185-90. PubMed ID: 19585361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.
    Mogyorósi A; Lippman HR; Feldman GM
    Am J Nephrol; 2002; 22(5-6):569-72. PubMed ID: 12381961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M; Schmiedeberg S; Becker J; Ruzicka T
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of presumptive primary immune-mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs.
    Cummings FO; Rizzo SA
    J Small Anim Pract; 2017 Feb; 58(2):96-102. PubMed ID: 28160307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful steroid withdrawal at the end of the 1st year after renal transplantion in mycophenolate mofetil-treated patients.
    Budde K; Hallebach G; Geissler S; Fritsche L; Diekmann F; Waiser J; Neumayer HH
    Transplant Proc; 2002 Aug; 34(5):1700-2. PubMed ID: 12176543
    [No Abstract]   [Full Text] [Related]  

  • 38. Complete but transient relief of chronic cluster headache with mycophenolate mofetil.
    Rozen TD
    Headache; 2004 Sep; 44(8):818-20. PubMed ID: 15330831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.
    Katz KH; Marks JG; Helm KF
    J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L; Christen W; Foster CS
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.